Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 147403-03-0 | MDL No. : | MFCD20278186 |
Formula : | C25H20N4O5 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KGSXMPPBFPAXLY-UHFFFAOYSA-N |
M.W : | 456.45 | Pubchem ID : | 135415867 |
Synonyms : |
TAK-536
|
Chemical Name : | 2-Ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylic acid |
Num. heavy atoms : | 34 |
Num. arom. heavy atoms : | 26 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 7 |
Num. H-bond acceptors : | 7.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 125.29 |
TPSA : | 123.24 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.99 cm/s |
Log Po/w (iLOGP) : | 2.48 |
Log Po/w (XLOGP3) : | 4.36 |
Log Po/w (WLOGP) : | 4.19 |
Log Po/w (MLOGP) : | 3.11 |
Log Po/w (SILICOS-IT) : | 4.19 |
Consensus Log Po/w : | 3.67 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -5.52 |
Solubility : | 0.00138 mg/ml ; 0.00000302 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -6.66 |
Solubility : | 0.000099 mg/ml ; 0.000000217 mol/l |
Class : | Poorly soluble |
Log S (SILICOS-IT) : | -8.19 |
Solubility : | 0.00000293 mg/ml ; 0.0000000064 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 3.55 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P501-P273-P202-P201-P280-P308+P313-P405 | UN#: | N/A |
Hazard Statements: | H361-H413 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
74.8 %Chromat. | With potassium <i>tert</i>-butylate In 1-methyl-pyrrolidin-2-one at 20℃; for 4 h; | Example 4 Methyl 2-ethoxy- 1 -((2'-(5-oxo-4,5-dihydro- 1 ,2,4-oxadiazol-3 -yl)biphenyl-4-yl)methyl)- 1 H- benzo[<i]imidazole-7-carboxylate of formula la0.05 g of the corresponding base was added to a mixture of 0.2 g of methyl 2-ethoxy- 1 -((2'- (A^-(methoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)-lH-benz[if]imidazole-7- carboxylate (of formula Vlaa; R' = Me) and 4 ml of the respective solvent, stirred in a reaction vial, and the mixture was stirred at the room temperature for 4 h. The collected samples were acidified with acetic acid and analyzed with HPLC. The results are summarized in Table I. Table I - Yield and purity of the product of Example 4 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
39.3 %Chromat. | With sodium ethanolate In dimethyl sulfoxide at 20℃; for 4 h; | Example 5Ethyl 2-ethoxy- 1 -((2'-(5-oxo-4,5-dihydro- 1 ,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)- 1 H- benzo[c ]imidazole-7-carboxylate of formula lb0.05 g of the corresponding base was added to a mixture of 0.2 g of ethyl 2-ethoxy- l -((2'-(N'- (ethoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)- l -benz[(i]imidazole-7- carboxylate (of formula VIbb; R' = Et) and 4 ml of the respective solvent, stirred in a reaction vial, and the mixture was stirred at the room temperature for 4 h. The collected samples were acidified with acetic acid and analyzed with HPLC. Table II - Yield and purity of the product of Example 5 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96.4% | Example 212-Ethoxy- l -((2'-(5-oxo-4,5-dihydro-l ,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-lH- benzo[c/]imidazole-7-carboxylic acid - <strong>[147403-52-9]azilsartan</strong> of formula IIA mixture of methyl 2-ethoxy- l -((2'-(5-oxo-4,5-dihydro- l ,2,4-oxadiazol-3-yl)biphenyl-4- yl)methyl)- l H-benzo[i ]imidazole-7-carboxylate (of formula la; 4.7 g, 10 mmol), methanol (50 ml) and aqueous sodium hydroxide (2 g of NaOH in 10 ml of water) was stirred at the room temperature for 24 hours. Then, methanol was evaporated and the residue was diluted with 50 ml of water and acidified with 5percent HCl. The insolubles were aspirated and washed with water. 4.4 g (96.4 percent) of a product containing 97.8 percent of <strong>[147403-52-9]azilsartan</strong> of formula II with the melting point of 208 to 21 1 °C according to HPLC was obtained. | |
96.8% | With sodium hydroxide; In water; at 60 - 65℃; | Azilsartan methyl ester (23.5 g, 0.05 mol)plusTo 120ml quality score5percent sodium hydroxide solution,The reaction was stirred at 60-65 ° C until TLC showed complete reaction (ca. 1 h)Cooled to 0-10 ,5percent diluted hydrochloric acid to adjust the pH to 3,Suction filtration, washed with crude,Recrystallized from ethanol to give 22.1g of white crystals,Yield 96.8percent |
96% | With potassium hydroxide; In water; at 75℃; for 1h; | In a 500 ml round-bottomed flask, compound (VII) (10 g, 21.3 mmol) and water (50 ml) were added and stirred well and added slowly.10percent potassium hydroxide solution (23.8 ml, 42.5 mmol), heated to 75 °C for 1 h,The TLC reaction is complete. Placed in an ice-water bath and lowered to 0°C, 1N hydrochloric acid was slowly added to pH=3 with stirring. The white solid of the filter cake recrystallized from absolute ethanol was 9.3 g of <strong>[147403-52-9]azilsartan</strong> (I) in a yield of 96percent. |
95.6% | With water; sodium hydroxide; at 20 - 30℃; for 2h; | 45 g (0.1 mol) of compound 2 (methyl ester) were dissolved in 450 ml of dimethylsulfoxide and separately controlled with carbon dioxideSpeed 80ml / min and flow rate 1.2L / min into the microreactor, after the temperature control unit in the reaction unit at 90-100 , PaulHold 1.0MPa pressure reaction for 60 seconds. The microreactor was obtained Azithromycin methyl ester solution by gas-liquid separator, adding 1mol / L hydrogenSodium hydroxide solution 450ml, the reaction temperature 20-30 ° C under stirring 2h, adding toluene 450ml, with hydrochloric acid to adjust the pH = 3-5,Liquid separation, after removal of toluene by adding ethanol 400ml, dissolved after cooling crystallization, and dried to give a white solid 43.6g, yield95.6percent, HPLC purity greater than 99.8percent. |
89.1% | With methanol; sodium hydroxide;Reflux; | A mixture of 65 g of the intermediate <strong>[147403-52-9]2-ethoxy-1-((2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)benzimidazole-7-carboxylic acid methyl ester</strong>, And 620 ml of methanol were charged into a reaction flask, turn on agitation,Then, 160 g of 10percent sodium hydroxide solution was added,Rose to reflux insulation reaction,Controlled by HPLC.After completion of the reaction, the temperature was lowered to 15-25 ° C,18 g of activated carbon was added,Stirring bleaching for half an hour.Filtered, washed with 30 ml of purified water,Filtration to dry, dropping hydrochloric acid,Adjust the pH to 2 to 3, adjust the mixing 1h, filter, with 30ml of purified water washing, filter to dry to get crude. The crude product was added to 200 ml of methanol, stirring, heating reflux 1h, cooling to 0 ~ 5 , stirring 1h, suction filtration,Washed with 20 ml of methanol, suction filtered to dryness,At 60 ~ 70 ° C to dry to dry azithentin into 56.1 g, yield 89.1percent, purity 99.6percent. |
88.7% | With methanol; sodium hydroxide; at 20℃; for 10h; | Into a 500 ml round bottom flask, 10 g of a raw material A4, 110 ml of methanol was added, and 28.8 ml of a 10percent NaOH solution was added under stirring at room temperature, and the reaction was stirred for 10 hours. After the reaction was completed, the methanol was spun dry. And adding 200 ml of water to the system, and adjusting the pH to 3-4 with HCl (1 mol/L), At this point a large amount of white solids are produced, suction filtration, Obtain crude product, separate and purify by column chromatography. Dichloromethane: methanol (1:20) gave 8.6 g of a white solid, yield 88.7percent, purity 97.4percent. |
88% | With pyrographite; potassium hydroxide; In water; at 50℃; for 1h; | 20 g of compound II-1 was added to a 5percent aqueous KOH solution.Stir the mixture to 50 ° C for 1 h, add activated carbon and continue to stir.Filter and collect the filtrate. Cool down to 10 ° C, adjust pH to 1 with hydrochloric acidFiltration, washing and drying to obtain Compound I, the yield is 88percent |
77.4% | With sodium hydroxide; at 73 - 75℃; for 2h; | Compound (5A) 2.0 g, placed in a reaction flask, 0.4mol / L sodium hydroxide, 32ml, 73-75 reaction for 2 hours.After the reaction was cooled to room temperature, a solution of aqueous acid solution to pH = 3-4, the precipitated white solid 1.5g, 77.4percent. |
75% | Example 3Preparation of l-[[2'-(4, 5-dihydro-5-oxo-4H-l, 2, 4-oxadiazol-3-yl) biphenyl-4-yl] methyl]-2-ethoxy-lH-benzimidazoIe-7-carboxylic Acid (Azilsartan)Methyl l-[[2'-(4,5-dihydro-5-oxo-4H-l,2,4-oxadiazol-3-yl) biphenyl-4-yl] methyl]-2-ethoxy-lH-benzimidazole-7-carboxylate (30 g) and NaOH solution (0.4 N; 475 ml) was stirred at 50-55°C for 30 min. Reaction mass was cool to 10-15°C and water was added. The pH of the resulting solution was adjusted to 2-3 by using 2 N HC1. Reaction mass was stirred for 30 mins. at 20-25°C. The product was filtered and dried under vacuum. The resulting product was suspended in isopropyl alcohol and was stirred for 25-30 mins. at 40-45°C. The product was filtered, washed and dried to obtain title compound. (Yield: 22 g; 75percent) | |
Example 11 2-Ethoxy- 1 -((2'-(5-oxo-4,5-dihydro- 1 ,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)- 1 H- benzo[c/]imidazole-7-carboxylic acid - <strong>[147403-52-9]azilsartan</strong> of formula IIA mixture of ethyl 2-ethoxy-l-((2'-(5-oxo-4,5-dihydro-l ,2,4-oxadiazol-3-yl)biphenyl-4- yl)methyl)-l H-benzo[< ]imidazole-7-carboxylate (of formula la; 3.2 g, 6.6 mmol) and aqueous sodium hydroxide (0.8 g of NaOH in 50 ml of water) was stirred at the temperature of 70°C for 1.5 hours. After cooling to the room temperature the mixture was acidified with 10percent HCl until pH 3 while being stirred and cooled. The insolubles were aspirated and washed with water. 2.6 g (86.2 percent) of a product was obtained containing 97.2 percent of <strong>[147403-52-9]azilsartan</strong> of formula II with the melting point of 208 to 21 1 °C according to HPLC. NMR spectrum: NMR (500 MHz, DMSO) delta (ppm): 13.17 (bs, 1H, OH or NH), 12.42 (bs, 1H, OH or NH), 7.70-7.60 (m, 3H, Ar), 7.57-7.50 (m, 2H, Ar), 7.50-7.44 (m, 1 H, Ar), 7.23 (d, J = 8.3 Hz, 2H, Ar), 7.18 (t, J = 7.9 Hz, lH, Ar), 7.05 (d, J = 8.3 Hz, 2H, Ar), 5.68 (s, 2H, N-CH2-Ar), 4.58 (q, J = 7.1 Hz, 2H, OCH2CH3), 1.38 (t, J = 7.1 Hz, 3H, OCH2CH3). | ||
With lithium hydroxide; In water; at 20℃; for 16h; | 10 g of the <strong>[147403-52-9]azilsartan</strong> intermediate compound I crystal obtained in this example dispersed in 45 mL of water. Then, 5.0 mL of lithium hydroxide aqueous solution with a solute mass fraction of 20percent was added. After stirring at room temperature for 16 hours, the aqueous solution was acidified with dilute hydrochloric acid to rhoH- = 3. Filtration and ethanol recrystallization gave <strong>[147403-52-9]azilsartan</strong> product with a purity of 99percent. | |
82.5 g | With lithium hydroxide; In methanol; water; for 3h;Reflux; | placed <strong>[147403-52-9]<strong>[147403-52-9]azilsartan</strong> methyl ester</strong> 100 g, methanol 730mL to 5000mL four-neck flask equipped with two stirring blades with a diameter of 15cm, was dissolved by heating with stirring.Was added thereto 2N aqueous lithium 590mL hydroxide, was heated to reflux temperature, the reaction was conducted for 3 hours.The resulting reaction solution was cooled to room temperature to prepare a pH of the reaction solution with 2N aqueous hydrochloric acid solution 3.And concentrating the reaction solution, the resulting residue in water 1200 mL, stirred with dichloromethane 3000 mL 30 minutes, allowed to stand for 15 minutes, was fractionated and the dichloromethane layer by a liquid.The resulting dichloromethane solution was concentrated to the resulting residue was stirred overnight at 20 to 30 ° C. was added ethyl acetate 2000 mL.Then, a sample was collected under reduced pressure filtered and precipitated crystals were dried at 50 ° C., to give colorless prisms of <strong>[147403-52-9]azilsartan</strong> of 82.5 g (<strong>[147403-52-9]azilsartan</strong> purity: 96.12percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine; In tetrahydrofuran; at 20℃; for 12h; | To a solution of 2-ethoxy-1-[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid (5.0 g) and triethylamine (1.69 mL) in THF (50 mL) was added dropwise 2,4,6-trichlorobenzoyl chloride (1.81 mL) under ice-cooling. After stirring the mixture at room temperature for 12 hrs, insoluble material was filtered off and the filtrate was concentrated. The residue was dissolved in methylene chloride (50 mL), and 4-hydroxymethyl-5-methyl-1,3-dioxol-2-one (1.72 g) and N,N-dimethylaminopyridine (1.61 g) were added under ice-cooling. After stirring the mixture at room temperature for 4 hrs, the reaction mixture was diluted with chloroform (150 mL), washed with water, saturated aqueous sodium hydrogen carbonate, 1N hydrochloric acid and saturated brine, dried over anhydrous sodium sulfate and concentrated. The residue was crystallized from diisopropyl ether to give crude crystals. The crude crystals were dissolved in ethanol (18 mL) with refluxing. Activated carbon (0.1 g) was added to the solution and the mixture was stirred with refluxing for 30 min. Insoluble material was filtered off and the filtrate was allowed to cool to room temperature. After 12 hrs., the precipitated crystals were collected by filtration and the crystals were washed with ice-cooled ethanol and dried under reduced pressure at room temperature to give the title compound (3.0 g, 50%). 4-Hydroxymethyl-5-methyl-1,3-dioxol-2-one was synthesised by the method described in Alpegiani, M.; Zarini, F.; Perrone, E. Synthetic Communication, Vol. 22, pp. 1277-1282 (1992). 1H NMR (300 MHz, DMSO-d6) delta: 1.37 (3H, t, J=7.2 Hz), 2.14 (3H, s), 4.58 (2H, q, J=7.2 Hz), 5.10 (2H, s), 5.53 (2H, s), 6.97 (2H, d, J=7.8 Hz), 7.17-7.22 (3H, m), 7.44-7.53 (3H, m), 7.61-7.73 (3H, m). To a solution of 2-ethoxy-1-[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid (4.0 g) and triethylamine (1.3 mL) in THF (50 mL) was added dropwise 2,4,6-trichlorobenzoyl chloride (1.4 mL) under ice-cooling. After stirring at room temperature for 12 hrs., insoluble material was filtered off and the filtrate was concentrated. The residue was dissolved in methylene chloride (50 mL) and 5-oxotetrahydro-2-furanyl (0.67 g) and N,N-dimethylaminopyridine (1.0 g) were added under ice-cooling. After stirring at room temperature for 4 hrs., the reaction mixture was diluted with chloroform (150 mL), washed with water, saturated aqueous sodium hydrogen carbonate, 1 N hydrochloric acid and saturated brine, dried over anhydrous sodium sulfate and concentrated. The residue was purified by silica gel column chromatography to give the title compound (0.16 g, 3.3%) as a colorless solid. 1H NMR (300 MHz, CDCl3) delta:1.48 (3H, t, J=7.1 Hz), 2.31-2.39 (1H, m), 2.45-2.66 (2H, m), 2.67-2.79 (1H, m), 4.63 (2H, q, J=7.1 Hz), 5.61 (1H, d, J=18 Hz), 5.81 (1H, d, J=18 Hz), 6.71-6.73 (1H, m), 6.98-7.01 (2H, m), 7.16-7.25 (3H, m), 7.36-7.38 (1H, m), 7.48-7.59 (3H, m), 7.69-7.80 (2H, m). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
22% | A solution of 2-ethoxy-1-[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid (1.0 g), 4-chloro-1,3-dioxolan-2-one (0.41 g) and triethylamine in DMF was stirred at 90 C. for 12 hrs. The reaction mixture was concentrated, and the residue was dissolved in chloroform and 1N hydrochloric acid. The organic layer was separated, dried over anhydrous sodium sulfate and concentrated. The residue was purified by silica gel column chromatography to give the title compound (0.20 g, 22%) as a colorless solid. 1H NMR (300 MHz, DMSO-d6) delta: 1.39 (3H, t, J=7.1 Hz), 4.52-4.65 (3H, m), 4.78 (1H, dd, J=5.8 Hz, 10.1 Hz), 5.55 (2H, d, J=2.6 Hz), 6.84 (1H, dd, J=2.1 Hz, 5.6 Hz), 7.03 (2H, d, J=8.3 Hz), 7.20-7.25 (3H, m), 7.43-7.57 (2H, m), 7.60-7.69 (3H, m), 7.77 (1H, dd, J=1.0 Hz, 7.8 Hz). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | To a solution of 2-ethoxy-1-[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid (9.0 g) and 4-hydroxymethyl-5-methyl-1,3-dioxol-2-one (3.08 g) in N,N-dimethylacetamide (100 mL) were added p-toluenesulfonyl chloride (4.13 g), N,N-dimethylaminopyridine (0.48 g) and potassium carbonate (3.54 g) under ice-cooling and the mixture was stirred at about 10 C. for 3 hrs. After adjusting the pH of the mixture to about 5, the mixture was crystallized by adding water (72 mL) to give crystals as a solvate. The isolated crystals were suspended in a mixture of water (63 mL) and acetone (27 mL) and the suspension was stirred at about 35 C. for 2 hrs. After stirring under ice-cooling for 2 hrs, the crystals were collected by filtration and the crystals were washed with water (18 mL) and dried under reduced pressure at 40 C. to give the title compound (10.6 g, 95%). 1H NMR (300 MHz, DMSO-d6) delta: 1.39 (3H, t, J=6.4 Hz), 2.17 (3H, s), 4.60 (2H, q, J=6.4 Hz), 5.12 (2H, s), 5.56 (2H, s), 7.00 (2H, d, J=7.0 Hz), 7.22-7.24 (3H, m), 7.46-7.57 (3H, m), 7.64-7.75 (3H, m). | |
81% | Example 5Preparation of (5-methyl-2-oxo-l, 3-dioxol-4yl) methyl 2-ethoxy-l-[[2'-(4, 5-dihydro- 5-oxo-4H-l, 2, 4-oxadiazoI-3-yl) biphenyl-4-yl] methyl]-2-ethoxy-lH-benzimidazole-7-carboxylate (<strong>[147403-03-0]Azilsartan</strong> medoxomi.) To a solution of l-[[2'-(4,5-dihydro-5-oxo-4H-l,2,4-oxadiazol-3-yl) biphenyl-4- yl] methyl]-2-ethoxy-lH-benzimidazole-7-carboxylic acid (5 g) in dimethylacetamide (55 ml), 4-hydroxymethyl-5-methyl-l,3-dioxol-2-one (2 g) was added at about 20-25C followed by cooling of the resulting solution to about -10 to -15C. To the resulting solution p-toluoyl sulfonylchloride (3 g), 4-dimethylaminopyridine (0.3 g) and K2C03 (2 g) was added at -10 to -15C. Temperature was. slowly raised to 10-15C in about 1-2 hrs followed by stirring at the same temperature for about 5-6 hrs. Water was added to the resulting solution at 15-20C. The pH of the solution was adjusted to 4-5 by using 0.5N HC1 solution followed by stirring for about 30 mins. The product was filtered, washed and dried to obtain title compound. (Yield: 5 g; 81%) | |
80.1% | With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl acetamide; at 8 - 10℃; for 3h; | Example 1: Preparation of crude <strong>[147403-03-0]azilsartan</strong> medoxomil according to EP21 19715 4-toluenesulfonyl chloride (19 g), 4-dimethylaminopyridine (2.5 g), and potassium carbonate (18 g) were added to a solution of 2-ethoxy-l-((2'-(5-oxo-4,5-dihydro-l ,2,4-oxadiazol-3- yl)bifenyl-4-yl)methyl)-lH-benzo[ ]-imidazole-7-carboxylic acid (42.8 g, 0.1 mol) and 4- hydroxymethyl-5-methyl-l,3-dioxol-2-one (16.3 g, 0.125 mol) in dimethylacetamide (450 ml) under cooling, and the mixture was stirred at a temperature of 8 - 10C for 3 hours. Then, pH of the mixture was adjusted to 4.5 - 5 by means of diluted hydrochloric acid and, after adding water, the precipitated insoluble portion was sucked off and washed with water. Then, the crude product was suspended in a water-acetone mixture and the mixture was stirred at 35C for 2 hours. After additional stirring in an ice bath for 2 hours, the insoluble portion was sucked off, washed with water, and dried under vacuum at 40C. 42.7 g of the substance (80.1%) was obtained. HPLC purity: 97.6%. |
80.1% | With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl acetamide; at 8 - 10℃; for 3h;Cooling; | 4-Toluenesulfonyl chloride (19 g), 4-dimethyl aminopyridine (2.5 g) and potassium carbonate (18 g) were added too a solution of 2-ethoxy-l-((2'-(5-oxo-4,5-dihydro-l,2,4-oxadiazol-3- yl)biphenyl-4-yl)methyl)-lH-benzo[i ]-imidazole-7-carboxylic acid (42.8 g, 0.1 mol) and 4- hydroxymethyl-5-methyl-l,3-dioxol-2-one (16.3 g, 0.125 mol) in dimethyl acetamide (450 ml) under cooling and the mixture was stirred at a temperature of 8-10C for 3 hours. Then, pH of the mixture was adjusted to 4.5-5 using diluted hydrochloric acid and the insoluble fraction, separated after addition of water, was aspirated and washed with water. After that, the crude product was suspended in a water-acetone mixture and the mixture was stirred at 35 C for 2 hours. After stirring for another 2 hours in an ice bath the insoluble fraction was aspirated, washed with water and dried in vacuo at 40C. 42.7 g of the substance (80.1 %) was obtained. HPLC purity: 97.6 %. |
3 g | With dmap; N,N-dimethyl acetamide; potassium carbonate; p-toluenesulfonyl chloride; at 0 - 5℃; for 2h; | To a mixture of 2-Ethoxy-l-[2'-(5-oxo-4,5-dihydro-l,2,4-oxadiazol-3- yl)biphenyl-4-yl]methyl}-lH-benzimidazole-7-carboxylic acid (5 gm) and N,N- dimethylacetamide (50 ml) were added to p-toluenesulfonyl chloride (3.5 gm), potassium carbonate (4 gm), N,N-dimethylaminopyridine (0.5 gm) and 4-hydroxymethyl-5-methyl- l,3-dioxol-2-one (3.5 gm) at 0 to 5C. The reaction mass was maintained for 2 hours at 0 to 5C and filtered through hi-flow bed. The pH of the filtrate thus obtained was adjusted to 2.0 with acetic acid and then added water (150 ml). The reaction mass was stirred for 30 minutes and filtered to provide a wet solid. To the wet solid was added acetone (15 ml) and water (35 ml) and maintained for 2 hours at room temperature. The contents were then cooled to 0 to 5C and maintained for 2 hours. The separated solid was filtered and then dried to provide 3 gm of <strong>[147403-03-0]azilsartan</strong> medoxomil crystalline Form I. |
92 g | With dmap; dicyclohexyl-carbodiimide; In ethyl acetate; at 15 - 20℃; | A mixture of <strong>[147403-03-0]azilsartan</strong> (I) (100 g), 4-(hydroxymethyl)-5-methyl-l,3-dioxol-2-one (VII) (40.68 g ), Nu,Nu'- dicyclohexylcarbodiimide (45.20 g),dimethyl aminopyridine (1.0 g) in ethylacetate (1000 ml) was stirred at 15-20C for 18-20 hours. The reaction mixture was filtered. The filtrate was washed with 5% sodium bicarbonate (500 ml) and was concentrated under vacuum. Acetonitrile (230 ml) was added to the residue and heated at 78-80C for 30 minutes. The mixture was cooled to 5-10C and stirred for 30 minutes. The solid was filtered, washed with acetonitrile and dried under vacuum. Yield: 92 g; HPLC purity: 99.43%. |
202 g | With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl acetamide; at 0 - 5℃; for 2h; | To a mixture of 2-Ethoxy-i-[2?-(5-oxo-4,5-dihy- dro-i ,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-i H-benzimidazole-7-carboxylic acid (200 gm) and N,N-dimethylacetamide (2000 ml) were added to p-toluenesulfonyl chloride (140gm), potassium carbonate (159 gm), N,N-dimethylaminopyridine (20 gm) and 4-hydroxymethyl-5-methyl-i ,3-di- oxol-2-one (140 gm) at 0 to 5 C. The reaction mass was maintained for 2 hours at 0 to 5 C. and filtered through hi-flow bed. The solvent was distilled off under vacuum below 75 C. to obtain a residual mass. To the residual mass was added ethyl acetate (2000 ml) and water (2000 ml) and pH was adjusted to 5.4 with hydrochloric acid (iN). The layers were separated and aqueous layer was extracted with ethyl acetate. Combined organic layers were dried with sodium sulfate and then concentrated to provide a residual solid. To the residual solid was added acetone (600 ml) and water (1400 ml) at 45 C. and then heated to 65 C. for 30 minutes. The contents were then cooled to room temperature and maintained for 1 hour 30 minutes. The separated solid was filtered and then dried to provide 202 gm of <strong>[147403-03-0]azilsartan</strong> medoxomil crystalline Form Hi. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | Reference Example 5 To methyl 2-ethoxy-1-[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate (10 g) was added 0.36N-NaOH (150 mL) and the mixture was stirred at 65-75°C for 1.5 hr. The mixture was adjusted to pH 8 at room temperature with 1N HCl, activated carbon (0.5 g) was added and the mixture was stirred. The activated carbon was filtered off and the residue was washed with water (50 mL). The mixture was adjusted to pH 3 with 0.5N HCl at 9-15°C. The mixture was stirred at 40-45°C and then at 5-15°C. The precipitated crystals were collected by filtration, washed with water (20 mL), and dried at 40°C to give compound A as a white powder (9.3 g, yield 96percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | Reference Example 4 To methyl 2-ethoxy-1-[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate (10 g) was added 0.40N-NaOH (167 mL) and the mixture was stirred at 65-75°C for 1-1.5 hr. The mixture was adjusted to pH 8 at room temperature with 1N HCl, activated carbon (0.5 g) was added and the mixture was stirred. The activated carbon was filtered off and the residue was washed with water (17 mL). The mixture was adjusted to pH 3 with 1N HCl at 0-5°C. The mixture was stirred at 40-45°C and then at 0-10°C. The precipitated crystals were collected by filtration, washed with water (17 mLx2 times), and dried at 40°C to give compound A as a white powder (9.3 g, yield 96percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In ethanol; water; at 20℃; for 26h;Reflux; | EXAMPLE 2 Preparation of <strong>[147403-03-0]Azilsartan</strong> choline <strong>[147403-03-0]Azilsartan</strong> (1.37 g) and 46% aqueous solution of choline (0.79 g) were added into ethanol (20 ml) and the mixture was heated to reflux for 2 hours, and then stirred for one day at room temperature. The mixture was dried under reduced pressure to remove the solvents. Ethyl acetate (20 ml) was added, then the mixture was stirred for 2 hours, and filterated to obtain white solid <strong>[147403-03-0]azilsartan</strong> choline.1H NMR (DMSO-d6+D2O) data: delta: 1.35 (t, 3H, CH3), 3.83 (t, 2H, CH2), 3.55 (t, 2H, CH2), 3.06 (s, 9H), 4.52 (q, 2H, CH2), 5.65 (s, 2H, CH2), 7.057.50 (m, 11H). | |
In methanol; water; for 3h;Reflux; | <strong>[147403-03-0]Azilsartan</strong> and Choline was Salified in a Molar Ratio of 1:1 [0038] <strong>[147403-03-0]Azilsartan</strong> (20.00 g, 0.0439 mol) was added into methanol (600.0 ml). The solution was supplemented with 46% of choline aqueous solution (11.80 g, 0.0439 mol) and stirred until clear. The reaction mixture was concentrated under reduced pressure. Isopropyl ether (100.0 ml) was added to the residue and the mixture was stirred to crystallization. After filtration and drying under vacuum, 18 g of white solid were obtained. [0039] 1H NMR (DMSO-d6) delta: 1.32 (t, 3H, CH3), 3.30 (s, 9H), 3.43 (t, 2H, CH2), 3.97 (t, 2H, CH2), 4.29 (q, 2H, CH2), 5.46 (s, 2H, CH2), 7.297.87 (m, 11H), 11.21 (br, 2H, NH, OH). Elemental analysis (%): C, 64.30; H, 6.02; N, 12.49. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In methanol; at 20℃;Reflux; | EXAMPLE 1 Preparation of <strong>[147403-03-0]Azilsartan</strong> ethanolamine <strong>[147403-03-0]Azilsartan</strong> (acid form) (1.37 g) was added into methanol (30 ml), then to the mixture ethanolamine (0.183 g) was added at room temperature and the resulting mixture was heated to reflux. The insoluble substance was filtered out, and the filtrate was concentrated under reduced pressure to remove solvent. Acetone (20 ml) was added into the residue, then the mixture was stirred for 2 hours, filtered, dried to obtain white solid 1.45 g <strong>[147403-03-0]Azilsartan</strong> ethanolamine.1H NMR (DMSO-d6+D2O) data: delta: 1.35 (t, 3H, CH3), 2.83 (t, 2H, CH2), 3.55 (t, 2H, CH2), 4.52 (q, 2H, CH2), 5.65 (s, 2H, CH2), 7.037.51 (m, 11H). | |
In methanol; | <strong>[147403-03-0]Azilsartan</strong> and Ethanolamine were Salified in a Molar Ratio of 1:1 [0042] <strong>[147403-03-0]Azilsartan</strong> (10.00 g, 0.0219 mol) was added into methanol (300.0 ml). The solution was supplemented with ethanolamine (1.34 g, 0.0219 mol) and stirred until clear. The reaction mixture was concentrated under reduced pressure. Isopropyl ether (100 ml) was added to the residue and the mixture was stirred to crystallization. After filtration and drying under vacuum, 10.30 g of white solid were obtained. [0043] 1H NMR (DMSO-d6) delta: 1.30 (t, 3H, CH3), 3.52 (t, 2H, CH2), 4.27 (t, 2H, CH2), 4.29 (q, 2H, CH2), 5.52 (s, 2H, CH2), 7.267.89 (m, 11H), 11.32 (br, 5H, NH, OH, NH3). Elemental analysis (%): C, 62.59; H, 5.32; N, 13.54. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96.4% | Example 102-Ethoxy- 1 -((2'-(5-oxo-4,5-dihydro- 1 ,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)- 1 H- benzo[i/]imidazole-7-carboxylic acid - azilsartan of formula IIA mixture of methyl 2-ethoxy-l -((2'-(5-oxo-4,5-dihydro-l ,2,4-oxadiazol-3-yl)biphenyl-4- yl)methyl)-lH-benzo[< ]imidazole-7-carboxylate (of formula la; 4.7 g, 10 mmol), methanol (50 ml) and aqueous sodium hydroxide (2 g of NaOH in 10 ml of water) was stirred at the room temperature for 24 hours. Then, methanol was evaporated and the residue was diluted with 50 ml of water and acidified with 5% HC1. The insolubles were aspirated and washed with water. 4.4 g (96.4 %) of a product containing 97.8 % of azilsartan of formula II with the melting point of 208 to 21 1 C according to HPLC was obtained. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Example 122-Ethoxy- 1 -((2'-(5-oxo-4,5-dihydro- 1 ,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)- 1H- benzo[( ]imidazole-7-carboxylic acid - azilsartan of formula IIA solution of ethyl chloroformate (2.7 g, 24.9 mmol) in dry DMF was added dropwise to a mixture of methyl 2-ethoxy-l -((2'-((hydroxyamino)iminomethyl)biphenyl-4-yl)methyl)-l H- benzo[i ]imidazole-7-carboxylate (of formula Va; 10.6 g, 23.8 mmol), dry DMF (75 ml) and pyridine (2.25 g)under stirring in an ice-cold bath under nitrogen and the mixture was stirred under cooling under nitrogen for 6 hours. The reaction mixture was poured into a separation funnel containing water (150 ml) and the mixture was extracted with ethyl acetate (5 x 100 ml). The extract was dried with MgS04 and, after evaporation, 12.7 g of a solid yellowish substance were obtained. The evaporation residue was dissolved in DMSO (200 ml) and t- BuOK (8 g, 71.3 mmol) was added under stirring and cooling and the mixture was stirred at the room temperature for 5 h. Then, the reaction mixture was poured into water (750 ml) and the resulting solution was acidified with 5 % HCl. The separated product was aspirated, washed with water and air-dried. 1 1.2 g (the quantitative yield would be ca. 10.9 g) of a product containing 88.3 % of azilsartan of formula II according to HPLC was obtained. Crystallization from isopropanol provided 9.3 g (85.5%) of azilsartan of formula II with the HPLC content of 98.7% with the melting point of 205 to 208 C. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
71.2%Chromat. | With sodium methylate; In tetrahydrofuran; at 20℃; for 4h; | Example 4 Methyl 2-ethoxy- 1 -((2'-(5-oxo-4,5-dihydro- 1 ,2,4-oxadiazol-3 -yl)biphenyl-4-yl)methyl)- 1 H- benzo[<i]imidazole-7-carboxylate of formula la0.05 g of the corresponding base was added to a mixture of 0.2 g of methyl 2-ethoxy- 1 -((2'- (A^-(methoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)-lH-benz[if]imidazole-7- carboxylate (of formula Vlaa; R' = Me) and 4 ml of the respective solvent, stirred in a reaction vial, and the mixture was stirred at the room temperature for 4 h. The collected samples were acidified with acetic acid and analyzed with HPLC. The results are summarized in Table I. Table I - Yield and purity of the product of Example 4 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
11.3%Chromat.; 72.7%Chromat. | With sodium methylate; In 1-methyl-pyrrolidin-2-one; at 20℃; for 4h; | Example 4 Methyl 2-ethoxy- 1 -((2'-(5-oxo-4,5-dihydro- 1 ,2,4-oxadiazol-3 -yl)biphenyl-4-yl)methyl)- 1 H- benzo[<i]imidazole-7-carboxylate of formula la0.05 g of the corresponding base was added to a mixture of 0.2 g of methyl 2-ethoxy- 1 -((2'- (A^-(methoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)-lH-benz[if]imidazole-7- carboxylate (of formula Vlaa; R' = Me) and 4 ml of the respective solvent, stirred in a reaction vial, and the mixture was stirred at the room temperature for 4 h. The collected samples were acidified with acetic acid and analyzed with HPLC. The results are summarized in Table I. Table I - Yield and purity of the product of Example 4 |
77.9%Chromat.; 17.1%Chromat. | With sodium methylate; In dimethyl sulfoxide; at 20℃; for 4h; | Example 4 Methyl 2-ethoxy- 1 -((2'-(5-oxo-4,5-dihydro- 1 ,2,4-oxadiazol-3 -yl)biphenyl-4-yl)methyl)- 1 H- benzo[<i]imidazole-7-carboxylate of formula la0.05 g of the corresponding base was added to a mixture of 0.2 g of methyl 2-ethoxy- 1 -((2'- (A^-(methoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)-lH-benz[if]imidazole-7- carboxylate (of formula Vlaa; R' = Me) and 4 ml of the respective solvent, stirred in a reaction vial, and the mixture was stirred at the room temperature for 4 h. The collected samples were acidified with acetic acid and analyzed with HPLC. The results are summarized in Table I. Table I - Yield and purity of the product of Example 4 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
7.9%Chromat.; 74.8%Chromat. | With potassium tert-butylate; In 1-methyl-pyrrolidin-2-one; at 20℃; for 4h;Product distribution / selectivity; | Example 4 Methyl 2-ethoxy- 1 -((2'-(5-oxo-4,5-dihydro- 1 ,2,4-oxadiazol-3 -yl)biphenyl-4-yl)methyl)- 1 H- benzo[<i]imidazole-7-carboxylate of formula la0.05 g of the corresponding base was added to a mixture of 0.2 g of methyl 2-ethoxy- 1 -((2'- (A^-(methoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)-lH-benz[if]imidazole-7- carboxylate (of formula Vlaa; R' = Me) and 4 ml of the respective solvent, stirred in a reaction vial, and the mixture was stirred at the room temperature for 4 h. The collected samples were acidified with acetic acid and analyzed with HPLC. The results are summarized in Table I. Table I - Yield and purity of the product of Example 4 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
66%Chromat. | With sodium ethanolate; In tetrahydrofuran; at 20℃; for 4h; | Example 5Ethyl 2-ethoxy- 1 -((2'-(5-oxo-4,5-dihydro- 1 ,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)- 1 H- benzo[c ]imidazole-7-carboxylate of formula lb0.05 g of the corresponding base was added to a mixture of 0.2 g of ethyl 2-ethoxy- l -((2'-(N'- (ethoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)- l -benz[(i]imidazole-7- carboxylate (of formula VIbb; R' = Et) and 4 ml of the respective solvent, stirred in a reaction vial, and the mixture was stirred at the room temperature for 4 h. The collected samples were acidified with acetic acid and analyzed with HPLC. Table II - Yield and purity of the product of Example 5 |
93%Chromat. | With potassium tert-butylate; In tetrahydrofuran; at 20℃; for 4h;Product distribution / selectivity; | Example 5Ethyl 2-ethoxy- 1 -((2'-(5-oxo-4,5-dihydro- 1 ,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)- 1 H- benzo[c ]imidazole-7-carboxylate of formula lb0.05 g of the corresponding base was added to a mixture of 0.2 g of ethyl 2-ethoxy- l -((2'-(N'- (ethoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)- l -benz[(i]imidazole-7- carboxylate (of formula VIbb; R' = Et) and 4 ml of the respective solvent, stirred in a reaction vial, and the mixture was stirred at the room temperature for 4 h. The collected samples were acidified with acetic acid and analyzed with HPLC. Table II - Yield and purity of the product of Example 5 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
39.3%Chromat.; 55.3%Chromat. | With sodium ethanolate; In dimethyl sulfoxide; at 20℃; for 4.0h;Product distribution / selectivity; | Example 5Ethyl 2-ethoxy- 1 -((2'-(5-oxo-4,5-dihydro- 1 ,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)- 1 H- benzo[c ]imidazole-7-carboxylate of formula lb0.05 g of the corresponding base was added to a mixture of 0.2 g of ethyl 2-ethoxy- l -((2'-(N'- (ethoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)- l -benz[(i]imidazole-7- carboxylate (of formula VIbb; R' = Et) and 4 ml of the respective solvent, stirred in a reaction vial, and the mixture was stirred at the room temperature for 4 h. The collected samples were acidified with acetic acid and analyzed with HPLC. Table II - Yield and purity of the product of Example 5 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84% | With water; sodium hydroxide; at 100℃; for 3h; | The second step: the O-acylated intermediate (5 mmol), NaOH (15 mmol) and 30 mL of water were added to a 100 mL two-necked flask, refluxed at 100 C for 3 h, cooled and allowed to stand, filtered, and the pH of the filtrate was adjusted with 1 mol/L of dilute HCl. To 3 to 4, the solid obtained by suction filtrationThe body was recrystallized from ethanol to give azilsartan with a purity of 99.5% and a yield of 84%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | With sodium hydroxide; In water; at 40℃; for 2h; | 2-ethoxy-1-[[2'-[N'((ethoxycarbonyl)oxy)carbamimidoyl][1,1-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid methyl ester2g3.39mmoL), 20mL of water, 10mL of 10% sodium hydroxide aqueous solution, reacted at 40 C for 2 hours, cooled, and adjusted to pH = 7 with aqueous IN hydrochloric acid solution, The solid was precipitated and filtered to give azilsartan(1. 53 g, 36.60 mmol) in a yield of 87% |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78.9% | Example 232-Ethoxy- l -((2'-(5-oxo-4, 5-dihydro- l, 2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)- 1H- benzo[<f]imidazole-7-carboxylic acid - azilsartan of formula II/-BuOK (0.56 g, 5.0 mmol) and diethyl carbonate (DMC; 0.6 g, 5.0 mmol) were added to a suspension of methyl 2-ethoxy- l -((2'-((hydroxyamino)iminomethyl)biphenyl-4-yl)methyl)- l H-benzo[c/]imidazole-7-carboxylate (of formula Va; 0.44 g, 1 mmol) in DMSO (5 ml) and the mixture was stirred at the temperature of 100C for 4 hours. The mixture did not contain the starting compound of formula Va, or the compound of formula la and the content of the compound of formula II was 82.5 % according to HPLC. Then, the reaction mixture was poured into water (20 ml) and the resulting solution was acidified with 5 % HC1. The separated product was aspirated, washed with water and air-dried. 0.45 g of a product was obtained, containing 87.3 % of azilsartan of formula II according to HPLC. Crystallization from isopropanol yielded 0.36 g (78.9 %) of azilsartan of formula II with the HPLC content of 95.2 % and melting point of 203 to 207 C. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
6.5 g | With dmap; triethylamine; In dichloromethane; at 0 - 30℃; for 1h; | Example 1 : Preparation of (2-Ethoxy-l- (r2'-(5-Oxo-4.5-Dihydro-1.2.4-Oxadiazol-3- Yl Biphenyl-4-YllMethyl}- lH-Benzimidazol-7-Yl -Carboxyl-4-Nitrophenyl Sulfonate Dichloromethane (50 mL) was added to <strong>[147403-03-0]azilsartan</strong> (5 g) at 20C to 30C. The reaction mixture was cooled to 0C to 5C. 4-Dimethylaminopyridine(0.27 g) was added to the reaction mixture at 5C. Triethylamine (2.33 g) was slowly added to the reaction mixture at 5C. A solution of 4-nitrobenzenesulfonyl chloride (2.91 g) in dichloromethane (25 mL) was slowly added to the reaction mixture at 0C to 5C. The temperature of the reaction mixture was raised to 20Cto 30C and it was stirred for 1 hour. The reaction mixture was washed with saturated sodium bicarbonate solution (25 mL). The organic layer was recovered at 40C under vacuum to obtainthe title compound.Yield: 6.5 g |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
6.5 g | Example 3 : Preparation of <strong>[147403-03-0]Azilsartan</strong> MedoxomilDichloromethane (50 mL) was added to <strong>[147403-03-0]azilsartan</strong> (5 g) at 20C to 30C. The reaction mixture was cooled to 0C to 5C.4-Dimethylaminopyridine (0.27 g) was added to the reaction mixture at 5C. Triethylamine (2.33 g) was slowly added to the reaction mixture at 5C. A solution of 4-nitrobenzenesulfonyl chloride (2.91 g) in dichloromethane (25 mL) was slowly added to the reaction mixture at 0C to 5C. The temperature of the reaction mixture was raised to 20C to 30C and it was stirred for 1 hour. 4- Hydroxymethyl-5-methyl- l,3-dioxol-2-one (1.71 g) and N,N-dimethylaminopyridine (1.41 g) were added to the reaction mixture at 20C to 30C. The temperature of the reaction mixture was raised to 35C to 40C and it was stirred for 1 hour. The reaction mixture was cooled to 20C to 30C and washed with IN hydrochloric acid (25 mL). The organic layer was washed with 5% sodium bicarbonate solution (25 mL). The organic layer was further washed with 25% sodium chloride solution (25 mL). The organic layer was recovered under vacuum at 25C to 30C. The solid obtained was recrystallized from diisopropylether (50 mL) and the solid obtained was filtered and washed withdiisopropylether (2 x 5 mL). The solid obtained was dried under vacuum at 25C to 30C to obtain the title compound having an X-ray powder diffraction pattern as depicted in Figure 1.Yield: 6.5 g |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In methanol; | <strong>[147403-03-0]Azilsartan</strong> and Ethanolamine was Salified in a Molar Ratio of 2:1 [0044] <strong>[147403-03-0]Azilsartan</strong> (10.00 g, 0.0219 mol) was added into methanol (300.0 ml). The solution was supplemented with ethanolamine (0.67 g, 0.0110 mol) and stirred until clear. The reaction mixture was concentrated under reduced pressure. The isopropyl ether (100 ml) was added to the residue and the mixture was stirred to crystallization. After filtration and drying under vacuum, 8.93 g of white solid were obtained. [0045] 1H NMR (DMSO-d6) delta: 1.33 (t, 6H, CH3), 3.09 (t, 2H, CH2), 3.60 (t, 2H, CH2), 4.30 (q, 4H, CH2), 5.46 (s, 4H, CH2), 7.287.93 (m, 22H), 11.013.0 (br, 7H, NH, CO2H, OH). Elemental analysis (%): C, 64.07; H, 4.79; N, 13.12. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In methanol; | <strong>[147403-03-0]Azilsartan</strong> and Piperazidine was Salified in a Molar Ratio of 2:1 [0046] <strong>[147403-03-0]Azilsartan</strong> (10.00 g, 0.0219 mol) was added into methanol (300.0 ml). The solution was supplemented with piperazidine (0.94 g, 0.0109 mol) and stirred until clear. The reaction mixture was concentrated under reduced pressure. Isopropyl ether (100 ml) was added to the residue and the mixture was stirred to crystallization. After filtration and drying under vacuum, 9.45 g of white solid were obtained. [0047] 1H NMR (DMSO-d6) delta: 1.34 (t, 6H, CH3), 2.68 (s, 8H, CH2), 4.31 (q, 4H, CH2), 5.47 (s, 4H, CH2), 7.277.92 (m, 22H), 11.20 (br, 6H, NH, CO2H). Elemental analysis (%): C, 64.79; H, 5.12; N, 14.15. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In methanol; ethanol; for 3h;Reflux; | <strong>[147403-03-0]Azilsartan</strong> and Choline were Salified in a Molar Ratio of 2:1 [0040] <strong>[147403-03-0]Azilsartan</strong> (10.00 g, 0.022 mol) and ethanol (100.0 ml) were added into a reaction flask and heated to reflux. The mixture was supplemented with 45% of choline-methanol solution (5.90 g, 0.022 mol) and stirred for 3 hours at the same temperature until the mixture turned into a clear solution. The reaction mixture was cooled to room temperature and stirred to crystallization. After filtration and drying under vacuum, 6.80 g of white solid were obtained. [0041] 1H NMR (DMSO-d6) delta: 1.38 (t, 6H, CH3), 3.09 (s, 9H), 3.39 (t, 2H, CH2), 3.82 (t, 2H, CH2), 4.58 (q, 4H, CH2), 5.69 (s, 4H, CH2), 7.057.61 (m, 22H), 11.07 (br, 4H, NH, OH, CO2H). Elemental analysis (%): C, 65.22; H, 5.42; N, 12.23. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86.4% | With dmap; potassium carbonate; p-toluenesulfonyl chloride; at 30℃; for 3h;Cooling; | 4-Toluenesulfonyl chloride (22 g), 4-dimethyl aminopyridine (1,6 g) and potassium carbonate (18.4 g) were added to a solution of 2-ethoxy-l-((2'-(5-oxo-4,5-dihydro-l,2,4-oxadiazol-3- yl)biphenyl-4-yl)memyl)-lH-benzo[i^-irnidazole-7-carboxylic acid (40 g) and 4- hydroxymethyl-5-methyl-l,3-dioxol-2-one (15 g) in dimethyl acetamide (400 ml) under cooling and the mixture was stirred at 30C 3 for 3 hours. Then, pH of the mixture was adjusted to 4.5-5 with the use of acetic acid and, after addition of water (210 ml), a product, 49.7 g (86.4 %) precipitated as a solvate with dimethyl acetamide. HPLC 97.3 %. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
98.5% | With water; sodium hydroxide; at 50℃; for 4.0h; | The starting <strong>[1403474-70-3]ethyl ester of azilsartan</strong> (V, 250 g) was suspended in a solution of sodium hydroxide in water (56 g/800ml). The suspension was heated at 50C for 4 h, after pH adjustment to 4-5, the product crystallized providing 232 g (98.5 %). |
93.4% | With sodium hydroxide; In water; at 70 - 75℃; for 1.5h; | 15g of AQST-3 intermediate was put into the flask, and 232g of the prepared 0.4mol / L sodium hydroxide solution was added. The temperature was raised to 70-75 C and the reaction was kept for about 1.5 hours. The reaction was monitored by TLC for completeness (no spots of AQST-3);After the reaction, drop to room temperature, filter, rinse the filter cake with a small amount of water, add 100ml of absolute ethanol to the filtrate, lower the temperature to 20-25 C and adjust the pH to 2 ~ 3 with 2mol / L diluted hydrochloric acid, and stir for about 1 hour. Filter and rinse to get crude AQST; |
91% | With pyrographite; sodium hydroxide; In water; at 55℃; for 2.0h; | 20 g of compound II-2 was added to a 15% aqueous NaOH solution.Stir the mixture to a temperature of 55 C for 2 h, add activated carbon and continue to stir.Filter and collect the filtrate. Cool down to 15 C, adjust the pH to 3 with hydrochloric acid,Filtration, washing with water, drying to obtain the finished compound I,The yield is 91%, |
89.3% | With sodium hydroxide; In ethanol; at 73 - 75℃; for 1.6h; | Compound (5B) 5 g, placed in a reaction flask, adding ethanol 30ml, was added dropwise 2.5mol / L sodium hydroxide 13ml, 73-75 1.6 hours the reaction.After completion of the reaction, cooled to room temperature, the solution was added dropwise to the acidic water pH = 3-4, to precipitate a white solid 4.2g, 89.3%. |
22 g | With water; sodium hydroxide; at 70 - 75℃; for 1.5h; | A mixture of azilsartan ester (VI; Ri= Et) (25 g) and 0.4 N NaOH solution (380 ml) was heated at 70-75C for 90 minutes. The reaction mixture was cooled to 10-15C and the pH was adjusted to 2.5-3.0 with 2 N HC1. The mixture was stirred for 30 minutes at 10- 15C. The solid was filtered, washed with water (100 ml) and dried under vacuum. Yield: 22.0 g;X-ray powder diffraction pattern as depicted in figure 1. |
50.6 g | With sodium hydroxide; at 75℃; | Example 2 Preparation of the product 2-Ethoxy-3- [2 '- (5-oxo-4,5-dihydro- [1,2,4] oxadiazol-3-yl) 4-ylmethyl] -3H-benzimidazole-4-carboxylate 55.1 g,0.4 MN NaOH into the reaction bottle,75 C stirring reaction to the raw material reaction is completed. The reaction solution was cooled to room temperature. The filtrate was added with 820ml of absolute ethanol, filtered and kept at 20 C. The pH was adjusted to 1 with 2M HC1 solution. A large amount of solid was precipitated, stirred for 1 hour, filtered and washed with water. 50.6 g,HPL (^ i ^ S 98.6% |
With ethanol; sodium hydroxide; at 75℃; | (4) Intermediate 3, 0.4 N NaOH solution, ethanol was added to the reaction kettle, the molar ratio of intermediate 3 to NaOH was 1:1.05, and the volume ratio of NaOH solution to ethanol was 1:1 at 75 C. Stirring, after completion of the reaction, cooling to room temperature, filtration, pH adjustment with 1N hydrochloric acid solution, to precipitate solids, stirring, filtration, adding ethanol to be beaten, filtering, and drying the filter cake to obtain crude azilsartan; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
94.84% | With water; sodium hydroxide; at 75℃; for 1h; | Azilsartan medoxomil (5.0g, 10.6mmol) into three-neck flask,A 2% aqueous solution of sodium hydroxide (60 ml, 30 mmol) was added,Heated to 75 C for 1 hour, hot filtered,The filtrate was added to 25 ml of acetone and the mixture was cooled to 0 C,Dropping 3% hydrochloric acid solution to pH to 2,20 C for 4 hours,Dried in vacuo to give azilsartan white solid, yield 94.84%,Purity 99.97%. Single miscellaneous less than 0.02%. |
With Bis(p-nitrophenyl) phosphate; In acetonitrile; at 37℃; for 0.0833333h;pH 7.4;Enzymatic reaction;Kinetics; | The OM-, CC- and AMhydrolaseactivities by recombinant human CMBL were measured with the10-mM prodrugs as substrates (final solvent concentration: 2.5% acetonitrile) intriplicate. After 5-minute preincubation, the reaction was initiated by adding thesubstrate. The prodrugs were incubated in 100 mM HEPES buffer (pH 7.4,incubation volume of 0.2 ml) at 37C for 5 minutes with 100 mg of the humanCMBL-transfected mammalian cell lysate constructed in-house (Ishizuka et al.,2010) as an enzyme source. The enzymatic activity was expressed asa metabolite formation rate (v0: nanomole per min per milligram protein)based on the production of azilsartan, from which the vector control wassubtracted as nonenzymatic hydrolysis.In addition, the kinetic analysis for AM hydrolysis by recombinant humanCMBL was carried out with a substrate range of 0.781-100 mM. The kineticconstant (Km) and maximum velocity (Vmax) for AM hydrolysis were estimatedusing WinNonlin Professional (version 1.4.1; Pharsight, Sunnyvale, CA) bya nonlinear least-squares regression analysis fitting to the Michaelis-Mentenequation, v0 = Vmax [S]/(Km + [S]), where v0 and [S] represent initial velocityand substrate concentration, respectively. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine; In 1-methyl-pyrrolidin-2-one; at 65℃; | QR01011-IN-01 (2.2mmol, 1.0 equiv.) and QR01002-IN-01 (3.3mmol, 1.5eq) were dissolved in 20mL N-methylpyrrolidone and triethylamine (4.4mmol, 2.0eq) was added and the reaction mixture was heated to 65C. TLC monitoring was done. When the reaction was complete, water and ethyl acetate was added and the organic later was separated and washed with water and saturated brine. The organic layer was dried and concetrated, purified by column chromatography to give the title compound QR01002. Its structure was confirmed by LCMS and NMR spectra. | |
With triethylamine; In 1-methyl-pyrrolidin-2-one; at 65℃; | The QR01000-IN-01 (2.2 mmol, 1.0 eq.) and the QR01002-IN-01 (3.3 mmol, 1.5 eq.) were dissolved in 20 mL of N-methylpyrrolidone, and then triethylamine (4.4 mmol, 2.0 eq.) was added thereto. The resulting mixture was heated to 65 C. and the TLC was used to monitor the reaction until the reaction is completed. To the reaction solution was added water and ethyl acetate, to perform an extraction, and the resulting organic layer was washed with water and saturated brine. The organic layer was dried and concentrated, and it is purified by column chromatography to give the title compound QR01002, its structure being dually confirmed by LCMS and NMRH spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine; In 1-methyl-pyrrolidin-2-one; at 65℃; | QR01011-IN-01 (2.2mmol, 1.0 equiv.) and QR01003-IN-01 (3.3mmol, 1.5eq) were dissolved in 20mL N-methylpyrrolidone and triethylamine (4.4mmol, 2.0eq) was added and the reaction mixture was heated to 65C. TLC monitoring was done. When the reaction was complete, water and ethyl acetate was added and the organic later was separated and washed with water and saturated brine. The organic layer was dried and concetrated, purified by column chromatography to give the title compound QR01002. Its structure was confirmed by LCMS and NMR spectra. | |
With triethylamine; In 1-methyl-pyrrolidin-2-one; at 65℃; | The QR01000-IN-01 (2.2 mmol, 1.0 eq.) and the QR01003-IN-01 (3.3 mmol, 1.5 eq.) were dissolved in 20 mL of N-methylpyrrolidone, and then triethylamine (4.4 mmol, 2.0 eq.) was added thereto. The resulting mixture was heated to 65 C. and the TLC was used to monitor the reaction until the reaction is completed. To the reaction solution was added water and ethyl acetate, to perform an extraction, and the resulting organic layer was washed with water and saturated brine. The organic layer was dried and concentrated, and it is purified by column chromatography to give the title compound QR01003, its structure being dually confirmed by LCMS and NMRH spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine; In 1-methyl-pyrrolidin-2-one; at 65℃; | QR01011-IN-01 (2.2mmol, 1.0 equiv.) and QR01004-IN-01 (3.3mmol, 1.5eq) were dissolved in 20mL N-methylpyrrolidone and triethylamine (4.4mmol, 2.0eq) was added and the reaction mixture was heated to 65C. TLC monitoring was done. When the reaction was complete, water and ethyl acetate was added and the organic later was separated and washed with water and saturated brine. The organic layer was dried and concetrated, purified by column chromatography to give the title compound QR01002. Its structure was confirmed by LCMS and NMR spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine; In 1-methyl-pyrrolidin-2-one; at 65℃; | QR01011-IN-01 (2.2mmol, 1.0 equiv.) and QR01005-IN-01 (3.3mmol, 1.5eq) were dissolved in 20mL N-methylpyrrolidone and triethylamine (4.4mmol, 2.0eq) was added and the reaction mixture was heated to 65C. TLC monitoring was done. When the reaction was complete, water and ethyl acetate was added and the organic later was separated and washed with water and saturated brine. The organic layer was dried and concetrated, purified by column chromatography to give the title compound QR01005. Its structure was confirmed by LCMS and NMR spectra. | |
With triethylamine; In 1-methyl-pyrrolidin-2-one; at 65℃; | The QR01000-IN-01 (2.2 mmol, 1.0 eq.) and the QR01005-IN-01 (3.3 mmol, 1.5 eq.) were dissolved in 20 mL of N-methylpyrrolidone, and then triethylamine (4.4 mmol, 2.0 eq.) was added thereto. The resulting mixture was heated to 65 C. and the TLC was used to monitor the reaction until the reaction is completed. To the reaction solution was added water and ethyl acetate, to perform an extraction, and the resulting organic layer was washed with water and saturated brine. The organic layer was dried and concentrated, and it is purified by column chromatography to give the title compound QR01005, its structure being dually confirmed by LCMS and NMRH spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl-formamide; at 10℃; for 3h; | QR01000-IN-01 (2.2mmol, 1.0eq) and QR01006-IN-01 (2.6mmol, 1.2eq) was dissolved in 20mL of dimethylformamide, cooled to 10C. Potassium carbonate (2.6mmol, 1.2 eq), p-toluenesulfonyl chloride (2.6mmol, 1.2eq), and the catalyst dimethylaminopyridine were stirred for 3h. Upon completion of the reaction, water was added to the reaction solution and the organic layer was extracted with ethyl acetate. The organic layer was washed with water and saturated brine. The crude product is dried and concentrated and purified by column chromatography to give the title compound QR01006. Its structure was confirmed by LCMS and NMR spectra. | |
With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl-formamide; at 10℃; for 3h; | The QR01000-IN-01 (2.2 mmol, 1.0 eq.) and the QR01006-IN-01 (2.6 mmol, 1.2 eq.) were dissolved in 20 ml of dimethylformamide, cooled to 10 C. To the resulting solution, potassium carbonate (2.6 mmol, 1.2 eq.), p-toluenesulfonyl chloride (2.6 mmol, 1.2 eq.), and a dimethylaminopyridine catalyst were added and the resulting mixture was stirred for 3 h. After the completion of the reaction, water was added to the reaction solution, extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine. Crude product was purified by column chromatography to give the title compound QR01006, its structure being dually confirmed by LCMS and NMRH spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl-formamide; at 10℃; for 3h; | QR01000-IN-01 (2.2mmol, 1.0eq) and QR01007-IN-01 (2.6mmol, 1.2eq) was dissolved in 20mL of dimethylformamide, cooled to 10C. Potassium carbonate (2.6mmol, 1.2 eq), p-toluenesulfonyl chloride (2.6mmol, 1.2eq), and the catalyst dimethylaminopyridine were stirred for 3h. Upon completion of the reaction, water was added to the reaction solution and the organic layer was extracted with ethyl acetate. The organic layer was washed with water and saturated brine. The crude product is dried and concentrated and purified by column chromatography to give the title compound QR01007. Its structure was confirmed by LCMS and NMR spectra. | |
With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl-formamide; at 10℃; for 3h; | The QR01000-IN-01 (2.2 mmol, 1.0 eq.) and the QR01007-IN-01 (2.6 mmol, 1.2 eq.) were dissolved in 20 ml of dimethylformamide, cooled to 10 C. To the resulting solution, potassium carbonate (2.6 mmol, 1.2 eq.), p-toluenesulfonyl chloride (2.6 mmol, 1.2 eq.), and a dimethylaminopyridine catalyst were added and the resulting mixture was stirred for 3 h. After the completion of the reaction, water was added to the reaction solution, extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine. Crude product was purified by column chromatography to give the title compound QR01007, its structure being dually confirmed by LCMS and NMRH spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl-formamide; at 10℃; for 3h; | QR01000-IN-01 (2.2mmol, 1.0eq) and QR01008-IN-01 (3.3mmol, 1.5eq) was dissolved in 20mL of dimethylformamide, cooled to 10C. Potassium carbonate (2.6mmol, 1.2 eq), p-toluenesulfonyl chloride (2.6mmol, 1.2eq), and the catalyst dimethylaminopyridine were stirred for 3h. Upon completion of the reaction, water was added to the reaction solution and the organic layer was extracted with ethyl acetate. The organic layer was washed with water and saturated brine. The crude product is dried and concentrated and purified by column chromatography to give the title compound QR01008. Its structure was confirmed by LCMS and NMR spectra. | |
With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl-formamide; at 10℃; for 3h; | The QR01000-IN-01 (2.2 mmol, 1.0 eq.) and the QR01008-IN-01 (3.3 mmol, 1.5 eq.) were dissolved in 20 ml of dimethylformamide, cooled to 10 C. Then, to the resulting solution, potassium carbonate (2.6 mmol, 1.2 eq.), p-toluenesulfonyl chloride (2.6 mmol, 1.2 eq.), and a dimethylaminopyridine catalyst were added and the resulting mixture was stirred for 3 h. After the completion of the reaction, water was added to the reaction solution, extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine. Crude product is purified by column chromatography to give the title compound QR01008, its structure being dually confirmed by LCMS and NMRH spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
94% | With dmap; triethylamine; p-toluenesulfonyl chloride; In dichloromethane; at 20℃; for 5h; | To a 100 ml three-necked flask was added lg of the compound of formula (2), 2.4 g of the compound of formula (3) and 50 ml of methylene chloride, followed by 1.2 g (1.2 eq) of p-toluenesulfonyl chloride and a catalytic amount of Dimethylaminopyridine and 1.33 g (2.5 eq) of triethylamine were stirred and dissolved based on the compound of formula (3), reacted for 5 h at room temperature, and then quenched by adding 50 ml of water. The mixture was extracted with dichloromethane (80 ml * 3). The combined organic layers were washed with saturated aqueous sodium bicarbonate, brine, dried over anhydrous sodium sulfate and spun dry to give 3.80 g of light yellow solid. The crude product was added with 20 ml of methyl tert-butyl ether Beating and suction filtration to obtain 3.08g of white solid powder, yield: 94%. |
With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl-formamide; at 10℃; for 3h; | QR01000-IN-01 (2.2mmol, 1.0eq) and QR01009-IN-02 (2.6mmol, 1.2eq) was dissolved in 20mL of dimethylformamide, cooled to 10C. Potassium carbonate (2.6mmol, 1.2 eq), p-toluenesulfonyl chloride (2.6mmol, 1.2eq), and the catalyst dimethylaminopyridine were stirred for 3h. Upon completion of the reaction, water was added to the reaction solution and the organic layer was extracted with ethyl acetate. The organic layer was washed with water and saturated brine. The crude product is dried and concentrated and purified by column chromatography to give the title compound QR01009. Its structure was confirmed by LCMS and NMR spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dicyclohexyl-carbodiimide; In dichloromethane; at 20℃; | QR01000-IN-01 (2.2mmol, 1.0eq) and QR01010-IN-02 (2.6mmol, 1.2eq) were dissolved in 20mL of dichloromethane and dicyclohexyl carbodiimide (4.4mmol, 2.0equiv.) was added, stirred at room temperature overnight. Upon completion of the reaction, water was added to the reaction solution, and the organic layer was extracted with methylene chloride. The organic layer was washed with water and saturated brine. The organic layer was dried and concentrated crude product was purified by column chromatography to give the title compound QR01010. Its structure was confirmed by LCMS and NMR spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; dicyclohexyl-carbodiimide; In dichloromethane; at 20℃; | QR01000-IN-01 (2.2mmol, 1.0eq) and QR01011-IN-05 (2.6mmol, 1.2eq) were dissolved in 20mL of dichloromethane and dicyclohexyl carbodiimide (4.4mmol, 2.0equiv.) and the catalyst dimethylaminopyridine were added, stirred at room temperature overnight. Upon completion of the reaction, water was added to the reaction solution, and the organic layer was extracted with methylene chloride. The organic layer was washed with water and saturated brine. The organic layer was dried and concentrated crude product was purified by column chromatography to give the title compound QR01011. Its structure was confirmed by LCMS and NMR spectra. | |
With dmap; dicyclohexyl-carbodiimide; In dichloromethane; at 20℃; | The QR01000-IN-01 (2.2 mmol, 1.0 eq.) and the QR01011-IN-02 (2.6 mmol, 1.2 eq.) were dissolved in 20 mL of dichloromethane, and dicyclohexyl carbodiimide (4.4 mmol, 2.0 eq.) and the dimethylaminopyridine catalyst were added thereto, stirred at room temperature overnight. After the completion of the reaction, water was added to the reaction solution, extracted with dichloromethane. The resulting organic layer was washed with water and saturated brine. Crude product is purified by column chromatography to give the title compound QR01011, its structure being dually confirmed by LCMS and NMRH spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; dicyclohexyl-carbodiimide; In dichloromethane; at 20℃; | QR01000-IN-01 (2.2mmol, 1.0eq) and QR01012-IN-03 (2.6mmol, 1.2eq) were dissolved in 20mL of dichloromethane and dicyclohexyl carbodiimide (4.4mmol, 2.0equiv.) and the catalyst dimethylaminopyridine were added, stirred at room temperature overnight. Upon completion of the reaction, water was added to the reaction solution, and the organic layer was extracted with methylene chloride. The organic layer was washed with water and saturated brine. The organic layer was dried and concentrated crude product was purified by column chromatography to give the title compound QR01012. Its structure was confirmed by LCMS and NMR spectra. | |
With dmap; dicyclohexyl-carbodiimide; In dichloromethane; at 20℃; | The QR01000-IN-01 (2.2 mmol, 1.0 eq.) and the QR01012-IN-02 (2.6 mmol, 1.2 eq.) were dissolved in 20 mL of dichloromethane, and dicyclohexyl carbodiimide (4.4 mmol, 2.0 eq.) and the catalyst dimethylaminopyridine were added thereto, stirred at room temperature overnight. After the completion of the reaction, water was added to the reaction solution, extracted with dichloromethane. The resulting organic layer was washed with water and saturated brine. Crude product is purified by column chromatography to give the title compound QR01012, its structure being dually confirmed by LCMS and NMRH spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl-formamide; at 10℃; for 3h; | QR01000-IN-01 (2.2mmol, 1.0eq) and QR01013-IN-04 (2.6mmol, 1.2eq) was dissolved in 20mL of dimethylformamide, cooled to 10C. Potassium carbonate (2.6mmol, 1.2 eq), p-toluenesulfonyl chloride (2.6mmol, 1.2eq), and the catalyst dimethylaminopyridine were stirred for 3h. Upon completion of the reaction, water was added to the reaction solution and the organic layer was extracted with ethyl acetate. The organic layer was washed with water and saturated brine. The crude product is dried and concentrated and purified by column chromatography to give the title compound QR01013. Its structure was confirmed by LCMS and NMR spectra. | |
With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl-formamide; at 10℃; for 3h; | The QR01000-IN-01 (2.2 mmol, 1.0 eq.) and the QR01013-IN-01 (2.6mmol, 1.2 eq) were dissolved in 20 ml of dimethylformamide, cooled to 10 C. To the resulting mixture, potassium carbonate (2.6 mmol, 1.2 eq.), p-toluenesulfonyl chloride (2.6 mmol, 1.2 eq.), and the catalyst dimethylaminopyridine were added and the resulting mixture is stirred for 3 h. After the completion of the reaction, water was added to the reaction solution, extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine. Crude product is purified by column chromatography to give the title compound QR01013, its structure being dually confirmed by LCMS and NMRH spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl-formamide; at 10℃; for 3h; | QR01000-IN-01 (2.2mmol, 1.0eq) and QR01014-IN-04 (2.6mmol, 1.2eq) was dissolved in 20mL of dimethylformamide, cooled to 10C. Potassium carbonate (2.6mmol, 1.2 eq), p-toluenesulfonyl chloride (2.6mmol, 1.2eq), and the catalyst dimethylaminopyridine were stirred for 3h. Upon completion of the reaction, water was added to the reaction solution and the organic layer was extracted with ethyl acetate. The organic layer was washed with water and saturated brine. The crude product is dried and concentrated and purified by column chromatography to give the title compound QR01014. Its structure was confirmed by LCMS and NMR spectra. | |
With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl-formamide; at 10℃; for 3h; | The QR01000-IN-01 (2.2 mmol, 1.0 eq.) and the QR01014-IN-01 (2.6 mmol, 1.2 eq.) were dissolved in 20 ml of dimethylformamide, cooled to 10 C. To the resulting mixture, potassium carbonate (2.6 mmol, 1.2 eq.), p-toluenesulfonyl chloride (2.6 mmol, 1.2 eq.), and the catalyst dimethylaminopyridine were added and the resulting mixture is stirred for 3 h. After the completion of the reaction, water was added to the reaction solution, extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine. Crude product is purified by column chromatography to give the title compound QR01014, its structure being dually confirmed by LCMS and NMRH spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine; In 1-methyl-pyrrolidin-2-one; at 65℃; | QR01011-IN-01 (2.2mmol, 1.0 equiv.) and QR01015-IN-01 (3.3mmol, 1.5eq) were dissolved in 20mL N-methylpyrrolidone and triethylamine (4.4mmol, 2.0eq) was added and the reaction mixture was heated to 65C. TLC monitoring was done. When the reaction was complete, water and ethyl acetate was added and the organic later was separated and washed with water and saturated brine. The organic layer was dried and concetrated, purified by column chromatography to give the title compound QR01015. Its structure was confirmed by LCMS and NMR spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl-formamide; at 10℃; for 3h; | QR01000-IN-01 (2.2mmol, 1.0eq) and QR01016-IN-01 (3.3mmol, 1.5eq) was dissolved in 20mL of dimethylformamide, cooled to 10C. Potassium carbonate (2.6mmol, 1.2 eq), p-toluenesulfonyl chloride (2.6mmol, 1.2eq), and the catalyst dimethylaminopyridine were stirred for 3h. Upon completion of the reaction, water was added to the reaction solution and the organic layer was extracted with ethyl acetate. The organic layer was washed with water and saturated brine. The crude product is dried and concentrated and purified by column chromatography to give the title compound QR01016. Its structure was confirmed by LCMS and NMR spectra. | |
With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl-formamide; at 10℃; for 3h; | The QR01000-IN-01 (2.2 mmol, 1.0 eq.) and the QR01016-IN-01 (3.3 mmol, 1.5 eq) were dissolved in 20 ml of dimethylformamide, cooled to 10 C. To the resulting solution, potassium carbonate (2.6 mmol, 1.2 eq.), p-toluenesulfonyl chloride (2.6 mmol, 1.2 eq.), and the catalyst dimethylaminopyridine were added and the resulting mixture was stirred for 3 h. After the completion of the reaction, water was added to the reaction solution, extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine. Crude product is purified by column chromatography to give the title compound QR01016, its structure being dually confirmed by LCMS and NMRH spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
586 mg | With triethylamine; In 1-methyl-pyrrolidin-2-one; at 65℃; for 2h; | Step (2): QR01000-IN-01 (0.77g, 1.69mmol), QR01017-IN-01 (0.62g, 2.54mmol), N-methylpyrrolidinone (15mL) and triethylamine (0.34g, 3.39mmol) were all aded in a 50mL flask. The mixture was stirred at 65C for 2 hours. TLC (dichloromethane:methanol=10:1) was done to check the reaction. Post-treatment: the reaction mixture was poured into 75mL water and was 1N HCl to adjust the pH to 6-7. The solution was a white emulsion. Methyl tert-butyl ether (50mL) was added for extraction and washed twice with saturated NaCl (50mLx2), then dried over anhydrous Na2SO4 to give 1.2 g of yellow liquid. Silica gel column was done to give 586mg white gum. LCMS and HNMR spectra confirmed the structure of the title compound QR01017. |
586 mg | With triethylamine; In 1-methyl-pyrrolidin-2-one; at 65℃; for 2h; | 10124] Step (2): to a 50 ml three-necked flask, the QRO1000-IN-01 (0.77 g, 1.69 mmol), the QRO1O17-IN-01 (0.62 g, 2.54 mmol), N-methylpyrrolidone (15 ml) and triethylamine (0.34 g, 3.39 mmol) were added in succession. The resultant mixture solution was stirred at 65 C. for 2 hours, and the TEC (methane dichloride:methanol=1 0:1) was used to monitor the reaction until it is fully carried out.10125] Post treatment: the reaction solution was poured into 75 ml of water, and then iN of HCE was added thereto to adjust the pH in the range of 6 to 7. The resulting solution is a white emulsion liquid. To the solution, methyl t-butyl ether (50 mE) was added to extract the solution, and the extract liquid was washed with saturated brine (50 mE*2) twice, dried with anhydrous Na2504, then dried by rotary evaporation, to give 1.2 g yellow liquid. The yellow liquid was purified by a silica-gel column to produce 586 mg of white gum, and the ECMS and HNMR spectra can confirm the structure of the target product QRO1O17. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
550 mg | With triethylamine; In 1-methyl-pyrrolidin-2-one; at 65℃; for 2h; | QR01000-IN-01 (0.77g, 1.69mmol), QR01019-IN-01 (0.62g, 2.4mmol), N-methylpyrrolidinone (15mL) and triethylamine (0.34g, 3.39mmol) were all aded in a 50mL flask. The mixture was stirred at 65C for 2 hours. TLC (dichloromethane:methanol=10:1) was done to check the reaction. Post-treatment: the reaction mixture was poured into 75mL water and was 1N HCl to adjust the pH to 6-7. The solution was a white emulsion. Methyl tert-butyl ether (50mL) was added for extraction and washed twice with saturated NaCl (50mLx2), then dried over anhydrous Na2SO4 to give 1.2 g of yellow liquid. Silica gel column was done to give 550mg white gum. LCMS and HNMR spectra confirmed the structure of the title compound QR01019. |
550 mg | With triethylamine; In 1-methyl-pyrrolidin-2-one; at 65℃; for 2h; | 10128] Step (2): to a 50 ml three-necked flask, the QRO1000-IN-01 (0.77 g, 1.69 mmol), the QRO1O19-IN-01 (0.62 g, 2.54 mmol), N-methylpyrrolidone (15 ml) and triethylamine (0.34 g, 3.39 mmol) were added in succession. The resultant mixture solution was stirred at 65 C. for 2 hours, and the TLC (methane dichloride:methanol1 0:1) was used to monitor the reaction until it is fully carried out. 10129] Post treatment: the reaction solution was poured into 75 ml of water, and then iN of HCL was added thereto to adjust the pH in the range of 6 to 7. The resulting solution is a white emulsion liquid. To the solution, methyl t-butyl ether (50 mL) was added to extract the solution, and the extract liquid was washed with saturated brine (50 mL*2) twice, dried with anhydrous Na2504, then dried by rotary evaporation, to give 1.2 g yellow liquid. The yellow liquid was purified by a silica-gel column to produce 550 mg of white gum, and the LCMS and HNMR spectra can confirm the structure of the target product QRO1 019. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
44.4% | With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl-formamide; at 20℃; for 3h; | In a 100mL QR01000-IN-01 (1.46g, 3.2mmol) was dissolved in 25mL N,N-dimethyl formamide, followed by adding QR01020-IN-01 (0.5g, 3.85mmol), p-toluenesulfonyl chloride (0.73g, 3.85mmol), potassium carbonate (0.88g, 6.4mmol) and a catalytic amount of N,N-dimethyl-pyridinamine (0.06g) and the reaction was stirred for 3 hours at room temperature. TLC (petroleum ether:ethyl acetate=1:3) was used to detect the completion of the reaction and a small amount of raw material QR01020-IN-01 remained. Post-treatment: the reaction mixture was added 50mL of water and extracted with ethyl acetate (60mL*3). The organic phase was washed with 100mL saturated sodium bicarbonate and 100mL saturated brine. It was dried over anhydrous sodium sulfate, filtered, spin dried to give 1.9g yellow oil. Upon liquid column chromatography (petroleum ether:ethyl acetate=1.5:1-1:2) gave a white solid 800mg, yield: 44.4%. LCMS and HNMR were used to confirm the structure of the target compound QR01023. |
44.4% | With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl-formamide; at 20℃; for 3h; | 10139] In a 100 ml one-necked flask, the QRO1000-IN-01 (1.46 g, 3.2 mmol) was dissolved in 25 mL of N,Ndimethylformamide, and then the QRO1O2O-IN-01 (0.5 g, 3.85 mmol), p-toluenesulfonyl chloride (0.73 g, 3.85 mmol), potassium carbonate (0.88 g, 6.4 mmol) and a catalytic amount of (0.06 g) of N,N-dimethylpyridine amine were added thereto in succession, stirred at room temperature for 3 hours. A new point is detected by the TLC (petroleum ether:ethyl acetate=1 :3), and a small quantity of the raw material QRO1O2O-IN-01 was still left. 10140] Post treatment: 50 ml of water were added to the resultant reaction solution, extraction with ethyl acetate (60 ml*3). The resultant organic phase was washed with 100 ml of saturated sodium bicarbonate and 100 ml of saturated brine, and it was dried with anhydrous sodium sulfate, filtrated, and dried by rotary evaporation, to give 1.9 g yellow oily liquid. The yellow oily liquid was separated by colunm chromatography (petroleum:ethyl acetate=1 .5:1 to 1:2), to produce 800 mg of white solid, with the yield of44.4%.j0141] LCMS and HNMR spectra In FIG. 1 can confirm the structure of the target compound QRO 1023, and in the LCMS spectrum, MS: 569.2. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; dicyclohexyl-carbodiimide; In dichloromethane; at 20℃; | QR01000-IN-01 (2.2mmol, 1.0eq) and QR01034-IN-02 (2.6mmol, 1.2eq) were dissolved in 20mL methylene chloride and was added with dicyclohexyl carbodiimide (4.4mmol, 2.0 equiv). Catalyst dimethylaminopyridine was added. Stirred at room temperature overnight. Upon completion of the reaction, water was added to the reaction solution, extracted with methylene chloride. The organic layer was washed with water ansd saturated brine. It was dried and concetrated and the crude was purified by column chromatography to give title compound QR01034. Its structure was confirmed by LCMS and HNMR spectra, |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl-formamide; at 10℃; for 3h; | QR01000-IN-01 (2.2mmol, 1.0eq) and QR01035-IN-03 (2.6mmol, 1.2eq) was dissolved in 20mL of dimethylformamide, cooled to 10C. Potassium carbonate (2.6mmol, 1.2 eq), p-toluenesulfonyl chloride (2.6mmol, 1.2eq), and the catalyst dimethylaminopyridine were stirred for 3h. Upon completion of the reaction, water was added to the reaction solution and the organic layer was extracted with ethyl acetate. The organic layer was washed with water and saturated brine. The crude product is dried and concentrated and purified by column chromatography to give the title compound QR01035. Its structure was confirmed by LCMS and NMR spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine; In 1-methyl-pyrrolidin-2-one; at 65℃; | QR01000-IN-01 (2.2mmol, 1.0 equiv.) and QR01036-IN-01 (3.3mmol, 1.5eq) were dissolved in 20mL N-methylpyrrolidone and triethylamine (4.4mmol, 2.0eq) was added and the reaction mixture was heated to 65C. TLC monitoring was done. When the reaction was complete, water and ethyl acetate was added and the organic later was separated and washed with water and saturated brine. The organic layer was dried and concetrated, purified by column chromatography to give the title compound QR01036. Its structure was confirmed by LCMS and NMR spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
18.9 g | In methanol; ethanol; for 0.5h;Reflux; | A 45% solution of choline in methanol (8.85 g, 0.033 mol),Was added to a flask containing ethanol (300.0Ml) in a reaction flask,in room temperature,Batch additionArsatan acid(30.00 g, 0.066 mol),The reaction mixture was heated to reflux for 30 minutes,The reaction was then cooled, concentrated to dryness,The resulting solidWas added methanol (150.0 ml)Heated to reflux stirring 30 minutes,Filtered in hot white solid.The resulting solid compound was confirmed to be structurally characterized by structural analysis in accordance with the compound of formula (II) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
40% | In methanol; at 20℃; for 2h; | AZ-2MI-H2O was obtained by dissolving AZ and 2MI (a total of120 mg of a 1:1 or 2:1 stoichiometric ratio of AZ and 2MI) in 20 mLof methanol/water (4:1, v/v) [ethanol/water or acetonitrile/water],and stirred at room temperature for 2 h. The resulting solution wasleft for slow evaporation. Colorless block crystals suitable for singlecrystal X-ray diffraction were obtained after 20 days. Yield: 48 mg(40%). Calcd for C27H25N5O6: C, 62.91%; H, 4.88%; N, 13.59%; found:C, 62.88%; H, 4.83%; N, 13.62%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
44% | In water; at 20℃; for 2h; | AZ-2MI-ACE was obtained by dissolving AZ and 2MI (a total of200 mg of a 1:1 stoichiometric ratio of AZ and 2MI) in 20 mL of theacetone/water mixture (3:1, v/v), and stirring at room temperaturefor 2 h. The resulting solution was left for slow evaporation.Colorless block crystals suitable for single crystal X-ray diffractionwere obtained after 7 days. Yield: 87 mg (44%). Calcd forC32H32N6O6: C, 64.42%; H, 5.41%; N, 14.09%; found: C, 64.39%; H,5.35%; N, 14.02%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
45% | In water; at 20℃; for 2h; | AZ-2MI-THF was obtained by dissolving AZ and 2MI (a total of200 mg of a 1:1 stoichiometric ratio of AZ and 2MI) in 20 mL of thetetrahydrofuran/water mixture (3:1, v/v), and stirring at roomtemperature for 2 h. The resulting solution was left for slowevaporation. Thick plate crystals suitable for single crystal X-raydiffraction were obtained after 7 days. Yield: 90 mg (45%). Calcd forC33H34N6O6: C, 64.91%; H, 5.61%; N, 13.76%; found: C, 64.87%; H,5.55%; N, 13.70%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
26% | With 2-methylimidazole; In water; at 20℃; for 2h; | AZ-DIO was obtained analogously with AZ-2MI-H2O, AZ-2MIACEand AZ-2MI-THF. AZ-DIO was obtained by dissolving AZ and2MI (a total of 120mg of a 1:1 stoichiometric ratio of AZ and 2MI) in20 mL of 1,4-dioxane/water (1:1, v/v), and stirring at room temperaturefor 2 h. The resulting solution was left for slow evaporation.The fine sheet crystals suitable for single crystal X-raydiffraction were obtained after 15 days. Yield: 31 mg (26%). Calcdfor C27H24N4O6: C, 64.79%; H, 4.83%; N, 11.19%; found: C, 64.72%; H,4.79%; N, 11.14%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine; In 1-methyl-pyrrolidin-2-one; at 65℃; | The QR01000-IN-01 (2.2 mmol, 1.0 eq.) and the QR01004-IN-01 (3.3 mmol, 1.5 eq.) were dissolved in 20 mL of N-methylpyrrolidone, and then triethylamine (4.4 mmol, 2.0 eq.) was added thereto. The resulting mixture was heated to 65 C. and the TLC was used to monitor the reaction until the reaction is completed. To the reaction solution was added water and ethyl acetate, to perform an extraction, and the resulting organic layer was washed with water and saturated brine. The organic layer was dried and concentrated, and it is purified by column chromatography to give the title compound QR01004, its structure being dually confirmed by LCMS and NMRH spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl-formamide; at 10℃; for 3h; | The QR01000-IN-01 (2.2 mmol, 1.0 eq.) and the QR01009-IN-01 (2.6 mmol, 1.2 eq.) were dissolved in 20 ml of dimethylformamide, cooled to 10 C. To the resulting solution, potassium carbonate (2.6 mmol, 1.2 eq.), p-toluenesulfonyl chloride (2.6 mmol, 1.2 eq.), and a dimethylaminopyridine catalyst were added and the resulting mixture was stirred for 3 h. After the completion of the reaction, water was added to the reaction solution, extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine. Crude product is purified by column chromatography to give the title compound QR01009, its structure being dually confirmed by LCMS and NMRH spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dicyclohexyl-carbodiimide; In dichloromethane; at 20℃; | The QR01000-IN-01 (2.2 mmol, 1.0 eq.) and the QR01010-IN-02 (2.6 mmol, 1.2 eq.) were dissolved in 20 mL of dichloromethane, and dicyclohexyl carbodiimide (4.4 mmol, 2.0 eq.) was added thereto, stirred at room temperature overnight. After the completion of the reaction, water was added to the reaction solution, extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine. Crude product is purified by column chromatography to give the title compound QR01010, its structure being dually confirmed by LCMS and NMRH spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine; In 1-methyl-pyrrolidin-2-one; at 65℃; | The QR01000-IN-01 (2.2 mmol, 1.0 eq.) and the QR01015-IN-01 (3.3 mmol, 1.5 eq) were dissolved in 20 mL N-methylpyrrolidone, and triethylamine (4.4 mmol, 2.0 eq.) was added thereto. The resulting mixture was heated to 65 C. and the TLC was used to monitor the reaction until the reaction is completed. To the reaction solution was added water and ethyl acetate, to perform an extraction, and the resulting organic layer was washed with water and saturated brine. The organic layer was dried and concentrated, and it was purified by column chromatography to give the title compound QR01015, its structure being dually confirmed by LCMS and NMRH spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; dicyclohexyl-carbodiimide; In dichloromethane; at 20℃; | 10181] The QRO1000-IN-01 (2.2 mmol, 1.0 eq.) and the QRO1O11-IN-02 (2.6 mmol, 1.2 eq.) were dissolved in 20 mE of dichloromethane, and then dicyclohexyl carbodiimide (4.4 mmol, 2.0 eq.) and the catalyst dimethylaminopyridine were added thereto and stirred at room temperature overnight. Afier the completion of the reaction, water was added to the reaction solution, extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine. Crude product was purified by column chromatography to give the title compound QR01034, its structure being confirmed by LCMS and NMRH spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; potassium carbonate; p-toluenesulfonyl chloride; In N,N-dimethyl-formamide; at 10℃; for 3h; | j0185] The QRO1000-IN-01 (2.2 mmol, 1.0 eq.) and the QR01035-IN-01 (2.6 mmol, 1.2 eq.) were dissolved in 20 ml of dimethylformamide, and the resultant solution is cooled to 10 C. Then, potassium carbonate (2.6 mmol, 1.2 eq.), p-toluenesulfonyl chloride (2.6 mmol, 1.2 eq.), and the catalyst dimethylaminopyridine were added to the solution, and the resultant mixture was stirred for 3 h. Afier the completion of the reaction, water was added to the reaction solution, extracted with ethyl acetate. The resulting organic layer was washed with water and saturated brine. Crude product was purified by column chromatography to give the title compound QR01035, its structure being confirmed by ECMS and NMRH spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine; In 1-methyl-pyrrolidin-2-one; at 65℃; | j0187] The QRO1000-IN-01 (2.2 mmol, 1.0 eq.) and the QR01036-IN-01 (3.3 mmol, 1.5 eq.) were dissolved in 20 mL N-methylpyrrolidone, and then triethylamine (4.4 mmol, 2.0 eq.) was added thereto. The resulting mixture was heated to 65 C. and the TLC was used to monitor the reaction until it was completed. To the reaction solution was added water and ethyl acetate, to perform an extraction, and the resulting organic layer was washed with water and saturated brine. The organic layer was dried and concentrated, and it was purified by column chromatography to give the title compound QR01036, its structure being dually confirmed by LCMS and NMRH spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | With hydrogenchloride; In ethanol; water; at 20℃; for 3h;pH 2; | <strong>[147403-03-0]Azilsartan</strong> (30 mg) was added to 10 mL of aqueous ethanol solution (1:1, v/v), and the solution was adjusted to pH = 2 by 1 M HCl and stirred at room temperature for 3 h. The solution left for slow evaporation. Colorless block crystals suitable for X-ray diffraction were obtained after 15 days upon solvent evaporation. Yield: 18 mg (60%), m.p.: 276-278 C. 1H-NMR (400 MHz, d6-DMSO) delta:13.15 (bs, 1H), 12.40 (s, 1H), 11.41 (s, 1H), 7.67-7.62 (m, 2H), 7.54 (td, J = 7.7, 1.2 Hz, 1H), 7.48 (d, J = 7.5, 1H), 7.34 (dd, J = 8.0, 1.2 Hz, 1H), 7.25-7.21 (m, 3H), 7.13-7.02 (m, 3H), 5.44 (s, 2H), 3.44 (q, J = 7.0 Hz, 2H), 1.06 (t, J = 7.1 Hz, 3H). |
With hydrogen bromide; In ethanol; at 78 - 85℃; for 1h; | 1, the <strong>[147403-03-0]azilsartan</strong> 10g (21.5mmol) was dissolved in 100ml of ethanol was heated with stirring, a solution of 40% HBr was added dropwise 21.75g (107.5mmol), dropwise at 78 ~ 85 IH reaction was stirred at reflux, cooled with stirring to 0 ~ 10 , filter, solid at 50 ~ 60 under reduced pressure drying 5h, too2-oxo-3 - [[2 '- (5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl) biphenyl-4-yl] methyl] 2,3-dihydro-1H- Benzimidazole-4-carboxylic acid8.3 g, yield 88.4%. 2, was added to the crude product 8g dimethylsulfoxide 100ml, heated and stirred were dissolved in 80 ~ 100 , filtered while hot, and the filtrate was cooled to -5 ~ 0 crystallization was stirred 2h, was filtered, the filter cake washed with an appropriate amount of ethanol,Solid at 50 ~ 60 under reduced pressure drying 5h, too2-oxo-3 - [[2 '- (5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl) biphenyl-4-yl] methyl] 2,3-dihydro-1H- Benzimidazole-4-carboxylic acid7.3 g, yield 91.3%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
89% | At room temperature (30 C), compound 01 (180 g, leq) was added to the reaction flask, Toluene (540 mL) and triethylamine (47.6 g, 1.2 eq), and a solution of ethyl chloroformate (51.1g, 1.2 eq) in toluene (180 mL) was added dropwise to the above reaction solution. After the dropwise addition, 2h, after the reaction, The reaction solution was cooled to room temperature, 600 mL of water was added, the toluene layer was added, DMAP (57.5 g, 1.2 eq) was added to the toluene layer, the mixture was heated to reflux, stirred for 3 hours, and the reaction solution was cooled to room temperature, Dropping 2 mol / L aqueous sodium hydroxide solution 1.2L stirring reaction 3h, the reaction solution pH value adjusted to 3.0, insulation stirring lh, The solid was rinsed with 200 mL of water and the solid was dried at 50 C for 12 h to give acesulfame (2) the total yield of about 89% |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
7.8 g | With dmap; p-toluenesulfonyl chloride; In N,N-dimethyl acetamide; at 10℃; for 3h;Cooling with ice; | To a reaction vessel placed in an ice bath was added <strong>[147403-03-0]azilsartan</strong>(8.59 g, 18.84 mmol), DMAc (80 ml), DMAP (0.5 g), TsCl (3.9 g) 4-hydroxymethyl-5-methyl-1,3-dioxol-2-one (2.4 g) was dissolved with stirring, Add the base in Table 1,After completion of the dropwise addition, the mixture was warmed to 10 C and stirred for 3 hours. The reaction was complete. 0.3 N HCl was added dropwise to the reaction solution, the pH was adjusted to 5, and then 60 ml of water was slowly added dropwise, The solid was precipitated, filtered, and 80 ml of acetone / water (VV: 1: 3) was added dropwise to the resulting solid, After stirring at 35 C for 2 hours, the mixture was stirred in an ice bath for 3 hours, filtered, 50C vacuum drying 10h <strong>[147403-03-0]Azilsartan</strong> tetramer 7.8g, Aztastamate HP LC purity and <strong>[147403-03-0]Azilsartan</strong> tetramer impurity content as shown in Table 1 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
71% | With n-butyllithium; In tetrahydrofuran; at -70℃;Inert atmosphere; | Under nitrogen atmosphere, the compound 8 (7.62 g, 15.6 mmol) is dissolved in 120 mLTHF in, lowering the temperature to -70 C, slow adds by drops positively BuLi (2.5 M, 14 ml), after the completion of the dropping, the dry carbon dioxide gas uniform speed of the blast to the reaction is complete, the temperature is raised to room temperature, and steaming and out most of the THF, then adding dilute hydrochloric acid (1 M) 80 ml, filter, the filter cake is ethanol recrystallization to obtain compound 10 (5.1 g, yield 71%) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
97.1% | With citric acid; In water; at 5℃;pH 5; | The compound of formula II is dissolved in an appropriate amount of water (all of the compound of formula II can be dissolved as appropriate), ice-cooled to 5 C, 20% citric acid was added dropwise to adjust the pH to 5, precipitated solid, filtered, rinsed the filter cake with water and dried to give A44.3 g of AZilsatan, the total yield of 97.1%, HPLC area normalized purity of 99.86% |
Tags: 147403-03-0 synthesis path| 147403-03-0 SDS| 147403-03-0 COA| 147403-03-0 purity| 147403-03-0 application| 147403-03-0 NMR| 147403-03-0 COA| 147403-03-0 structure
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :